img

Cancer Genome Sequencing Market Status and Trend Analysis 2017-2034 (COVID-19 Version)


Published on: 2024-01-04 | No of Pages : 98 | Industry : Life & Medical

Publisher : 9 | Format : PDF

Cancer Genome Sequencing Market Status and Trend Analysis 2017-2034 (COVID-19 Version)

Summary

Further key aspects of the report indicate that
Chapter 1Research ScopeProduct Definition, Type, End-Use & Methodology
Chapter 2Global Industry Summary
Chapter 3Market Dynamics
Chapter 4Global Market Segmentation by region, type and End-Use
Chapter 5North America Market Segmentation by region, type and End-Use
Chapter 6Europe Market Segmentation by region, type and End-Use
Chapter 7Asia-Pacific Market Segmentation by region, type and End-Use
Chapter 8South America Market Segmentation by region, type and End-Use
Chapter 9Middle East and Africa Market Segmentation by region, type and End-Use.
Chapter 10Market Competition by Companies
Chapter 11Market forecast and environment forecast.
Chapter 12Industry Summary.

The global Cancer Genome Sequencing market has the potential to grow with xx million USD with growing CAGR in the forecast period from 2021f to 2026f. Factors driving the market for @@@@@ are the significant development of demand and improvement of COVID-19 and geo-economics.


Based on the type of product

the global Cancer Genome Sequencing market segmented into
Second generation
Third generation

Based on the end-use

the global Cancer Genome Sequencing market classified into
Treatment
Research

Based on geography

the global Cancer Genome Sequencing market segmented into
North America [U.S., Canada, Mexico]
Europe [Germany, UK, France, Italy, Rest of Europe]
Asia-Pacific [China, India, Japan, South Korea, Southeast Asia, Australia, Rest of Asia Pacific]
South America [Brazil, Argentina, Rest of Latin America]
Middle East & Africa [GCC, North Africa, South Africa, Rest of Middle East and Africa]

And the major players included in the report are


Agilent Technologies
GE Healthcare Life Sciences
Johnson & Johnson
LI-COR Biosciences
Abbott Laboratories
Beckman Coulter
Bayer Corporation
Hamilton Thorne Biosciences
Microchip Biotechnologies
Myriad Genetics
Commonwealth Biotechnologies
ZS Genetics
Pacific Biosciences

Table of Content

Table of Contents
1 RESEARCH SCOPE
1.1 Research Product Definition
1.2 Research Segmentation
1.2.1 Product Type
1.2.2 Main product Type of Major Players
1.3 Demand Overview
1.4 Research Methodology
2 GLOBAL CANCER GENOME SEQUENCING INDUSTRY
2.1 Summary about Cancer Genome Sequencing Industry
2.2 Cancer Genome Sequencing Market Trends
2.2.1 Cancer Genome Sequencing Production & Consumption Trends
2.2.2 Cancer Genome Sequencing Demand Structure Trends
2.3 Cancer Genome Sequencing Cost & Price
3 MARKET DYNAMICS
3.1 Manufacturing & Purchasing Behavior in 2020
3.2 Market Development under the Impact of COVID-19
3.2.1 Drivers
3.2.2 Restraints
3.2.3 Opportunity
3.2.4 Risk
4 GLOBAL MARKET SEGMENTATION
4.1 Region Segmentation (2017 to 2021f)
4.1.1 North America (U.S., Canada and Mexico)
4.1.2 Europe (Germany, UK, France, Italy, Rest of Europe)
4.1.3 Asia-Pacific (China, India, Japan, South Korea, Southeast Asia, Australia, Rest of Asia Pacific)
4.1.4 South America (Brazil,, Argentina, Rest of Latin America)
4.1.5 Middle East and Africa (GCC, North Africa, South Africa, Rest of Middle East and Africa)
4.2 Product Type Segmentation (2017 to 2021f)
4.2.1 Second generation
4.2.2 Third generation
4.3 Consumption Segmentation (2017 to 2021f)
4.3.1 Treatment
4.3.2 Research
5 NORTH AMERICA MARKET SEGMENT
5.1 Region Segmentation (2017 to 2021f)
5.1.1 U.S.
5.1.2 Canada
5.1.3 Mexico
5.2 Product Type Segmentation (2017 to 2021f)
5.2.1 Second generation
5.2.2 Third generation
5.3 Consumption Segmentation (2017 to 2021f)
5.3.1 Treatment
5.3.2 Research
5.4 Impact of COVID-19 in North America
6 EUROPE MARKET SEGMENTATION
6.1 Region Segmentation (2017 to 2021f)
6.1.1 Germany
6.1.2 UK
6.1.3 France
6.1.4 Italy
6.1.5 Rest of Europe
6.2 Product Type Segmentation (2017 to 2021f)
6.2.1 Second generation
6.2.2 Third generation
6.3 Consumption Segmentation (2017 to 2021f)
6.3.1 Treatment
6.3.2 Research
6.4 Impact of COVID-19 in Europe
7 ASIA-PACIFIC MARKET SEGMENTATION
7.1 Region Segmentation (2017 to 2021f)
7.1.1 China
7.1.2 India
7.1.3 Japan
7.1.4 South Korea
7.1.5 Southeast Asia
7.1.6 Australia
7.1.7 Rest of Asia Pacific
7.2 Product Type Segmentation (2017 to 2021f)
7.2.1 Second generation
7.2.2 Third generation
7.3 Consumption Segmentation (2017 to 2021f)
7.3.1 Treatment
7.3.2 Research
7.4 Impact of COVID-19 in Europe
8 SOUTH AMERICA MARKET SEGMENTATION
8.1 Region Segmentation (2017 to 2021f)
8.1.1 Brazil
8.1.2 Argentina
8.1.3 Rest of Latin America
8.2 Product Type Segmentation (2017 to 2021f)
8.2.1 Second generation
8.2.2 Third generation
8.3 Consumption Segmentation (2017 to 2021f)
8.3.1 Treatment
8.3.2 Research
8.4 Impact of COVID-19 in Europe
9 MIDDLE EAST AND AFRICA MARKET SEGMENTATION
9.1 Region Segmentation (2017 to 2021f)
9.1.1 GCC
9.1.2 North Africa
9.1.3 South Africa
9.1.4 Rest of Middle East and Africa
9.2 Product Type Segmentation (2017 to 2021f)
9.2.1 Second generation
9.2.2 Third generation
9.3 Consumption Segmentation (2017 to 2021f)
9.3.1 Treatment
9.3.2 Research
9.4 Impact of COVID-19 in Europe
10 COMPETITION OF MAJOR PLAYERS
10.1 Brief Introduction of Major Players
10.1.1 Agilent Technologies
10.1.2 GE Healthcare Life Sciences
10.1.3 Johnson & Johnson
10.1.4 LI-COR Biosciences
10.1.5 Abbott Laboratories
10.1.6 Beckman Coulter
10.1.7 Bayer Corporation
10.1.8 Hamilton Thorne Biosciences
10.1.9 Microchip Biotechnologies
10.1.10 Myriad Genetics
10.1.11 Commonwealth Biotechnologies
10.1.12 ZS Genetics
10.1.13 Pacific Biosciences
10.2 Cancer Genome Sequencing Sales Date of Major Players (2017-2020e)
10.2.1 Agilent Technologies
10.2.2 GE Healthcare Life Sciences
10.2.3 Johnson & Johnson
10.2.4 LI-COR Biosciences
10.2.5 Abbott Laboratories
10.2.6 Beckman Coulter
10.2.7 Bayer Corporation
10.2.8 Hamilton Thorne Biosciences
10.2.9 Microchip Biotechnologies
10.2.10 Myriad Genetics
10.2.11 Commonwealth Biotechnologies
10.2.12 ZS Genetics
10.2.13 Pacific Biosciences
10.3 Market Distribution of Major Players
10.4 Global Competition Segmentation
11 MARKET FORECAST
11.1 Forecast by Region
11.2 Forecast by Demand
11.3 Environment Forecast
11.3.1 Impact of COVID-19
11.3.2 Geopolitics Overview
11.3.3 Economic Overview of Major Countries
12 REPORT SUMMARY STATEMENT

List of Figure

List of Table
Table Cancer Genome Sequencing Product Type Overview
Table Cancer Genome Sequencing Product Type Market Share List
Table Cancer Genome Sequencing Product Type of Major Players
Table Brief Introduction of Agilent Technologies
Table Brief Introduction of GE Healthcare Life Sciences
Table Brief Introduction of Johnson & Johnson
Table Brief Introduction of LI-COR Biosciences
Table Brief Introduction of Abbott Laboratories
Table Brief Introduction of Beckman Coulter
Table Brief Introduction of Bayer Corporation
Table Brief Introduction of Hamilton Thorne Biosciences
Table Brief Introduction of Microchip Biotechnologies
Table Brief Introduction of Myriad Genetics
Table Brief Introduction of Commonwealth Biotechnologies
Table Brief Introduction of ZS Genetics
Table Brief Introduction of Pacific Biosciences
Table Products & Services of Agilent Technologies
Table Products & Services of GE Healthcare Life Sciences
Table Products & Services of Johnson & Johnson
Table Products & Services of LI-COR Biosciences
Table Products & Services of Abbott Laboratories
Table Products & Services of Beckman Coulter
Table Products & Services of Bayer Corporation
Table Products & Services of Hamilton Thorne Biosciences
Table Products & Services of Microchip Biotechnologies
Table Products & Services of Myriad Genetics
Table Products & Services of Commonwealth Biotechnologies
Table Products & Services of ZS Genetics
Table Products & Services of Pacific Biosciences
Table Market Distribution of Major Players
Table Global Major Players Sales Revenue (Million USD) 2017-2020e
Table Global Major Players Sales Revenue (Million USD) Share 2017-2020e
Table Global Cancer Genome Sequencing Market Forecast (Million USD) by Region 2021f-2026f
Table Global Cancer Genome Sequencing Market Forecast (Million USD) Share by Region 2021f-2026f
Table Global Cancer Genome Sequencing Market Forecast (Million USD) by Demand 2021f-2026f
Table Global Cancer Genome Sequencing Market Forecast (Million USD) Share by Demand 2021f-2026f